Free Trial
NYSEARCA:XPH

SPDR S&P Pharmaceuticals ETF (XPH) Price, Holdings, & News

$43.62 +0.45 (+1.04%)
As of 10:37 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Key Stats

Today's Range
$43.27
$43.73
50-Day Range
$40.58
$43.37
52-Week Range
$35.22
$48.76
Volume
2,912 shs
Average Volume
46,997 shs
Market Capitalization
$157.03 million
Assets Under Management
$153.12 million
Dividend Yield
1.35%
Net Expense Ratio
0.35%
Aggregate Rating
Moderate Buy

ETF Overview

SPDR S&P Pharmaceuticals ETF Expenses

TypeXPHHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.35%0.56%0.56%0.51%0.53%
Other Expenses0.00%0.47%0.56%0.59%0.56%
Total Expense0.35%0.75%0.76%0.74%0.73%
Fee Waiver0.00%-0.67%-0.66%-0.71%-0.63%
Net Expense0.35%0.60%0.63%0.58%0.60%
Receive XPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SPDR S&P Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

XPH ETF News Headlines

XPH: Healthcare Dashboard For July
This stock could leave NVDA in the dust
Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.
Capture European Growth with This Banking-Focused ETF
See More Headlines

XPH ETF - Frequently Asked Questions

SPDR S&P Pharmaceuticals ETF's stock was trading at $42.99 at the beginning of 2025. Since then, XPH stock has increased by 0.4% and is now trading at $43.17.

Top institutional shareholders of SPDR S&P Pharmaceuticals ETF include Kingsview Wealth Management LLC (6.58%), First Citizens Bank & Trust Co. (4.90%), Envestnet Portfolio Solutions Inc. (4.47%) and Rockefeller Capital Management L.P. (0.57%).

Shares of XPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that SPDR S&P Pharmaceuticals ETF investors own include NVIDIA (NVDA), Pfizer (PFE), Adobe (ADBE), Applied Materials (AMAT), Chevron (CVX), JPMorgan Chase & Co. (JPM) and Meta Platforms (META).

Fund Details

Issuer
SSgA
Fund Name
SPDR S&P Pharmaceuticals ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:XPH
Inception Date
6/19/2006
Fund Manager
Michael Feehily, Karl Schneider, Keith Richardson

Fund Focus

Asset Class
Equity
Benchmark
S&P Pharmaceuticals Select Industry Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
53

Fund Statistics

Assets Under Management
$153.12 million
Average Daily Volume
$42.42 thousand
Discount/Premium
0.04%

Administrator, Advisor and Custodian

Administrator
SSgA Funds Management, Inc.
Advisor
SSgA Funds Management, Inc.
Custodian
State Street Bank and Trust Company
Distributor
State Street Global Advisors Funds Distributors, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Citadel

Options

Optionable
Optionable
Options Volume
3
Put Options
3
Call Options
1
Short Interest
999,000 shs

Miscellaneous

Beta
0.84
Creation Unit
50,000
Creation Fee
$250.00
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Top 10 XPH Holdings

XPH Sector Exposure

XPH Industry Exposure


This page (NYSEARCA:XPH) was last updated on 8/11/2025 by MarketBeat.com Staff
From Our Partners